BioSpace News Archive

Policy

Orexo Regains Rights to Zubsolv® in all Countries Outside the US

Orexo AB today announces that the Company will regain the rights to Zubsolv (buprenorphine and naloxone sublingual tablet) for the treatment of opioid dependence in all territories outside the United States from its current partner, Mundipharma, on April 13, 2019.

December 13, 2018
·
3 min read
Policy

ERS Genomics and Lonza Enter Into CRISPR/Cas9 Technology Licensing Deal

ERS Genomics Limited and Lonza Pharma & Biotech announced today a license agreement to provide Lonza with access to ERS Genomics’ CRISPR/Cas9 genome editing technology patents.

December 13, 2018
·
1 min read
Policy

ConsumerMedical achieves HITRUST Certification

ConsumerMedical has recently received Certification from the Health Information Trust (HITRUST) Alliance.

December 13, 2018
·
1 min read
Business

Boehringer Ingelheim and Lilly Partner with Duke Clinical Research Institute to Advance Multidisciplinary Care for People with Type 2 Diabetes and Cardiovascular Disease

The Duke Clinical Research Institute (DCRI) is leading a new clinical study to optimize care for people with type 2 diabetes and cardiovascular disease through evaluation of a multidisciplinary approach at cardiology clinics across the U.S.

December 13, 2018
·
7 min read
FDA Grants Fast Track Designation to the Baricitinib Development Program for the Treatment of Systemic Lupus Erythematosus (SLE)

Eli Lilly and Company (NYSE: LLY) and Incyte Corporation (NASDAQ: INCY) announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to baricitinib,

December 13, 2018
·
12 min read
BioMidwest

Scientists Create Most Accurate Tool Yet Developed To Predict Asthma in Young Children

Scientists at Cincinnati Children’s Hospital Medical Center have created and tested a decision tool that appears to be the most accurate, non-invasive method yet developed to predict asthma in young children.

December 13, 2018
·
3 min read
Deals

Akebia Therapeutics and Keryx Biopharmaceuticals Complete Merger, Creating Fully Integrated Renal Company

Akebia Therapeutics, Inc. and Keryx Biopharmaceuticals, Inc. today announced the successful completion of their previously announced merger.

December 13, 2018
·
7 min read
BioCapital

Sixteen Years in the Making, National Geographic Unveils a Behind-the-Scenes Look at the Creation of the Highest-Quality Imagery of a Human Body in Existence

Today, National Geographic releases “The Immortal Corpse,” a story, 16-years in the making, that chronicles the life, death and digital resurrection of Susan Potter and her impact on the future of medicine for decades to come.

December 13, 2018
·
6 min read
Business

National Alliance of Wound Care and Ostomy® Announces Retirement of Cheryl Robillard from Board of Directors

The National Alliance of Wound Care and Ostomy® (NAWCO®) Board of Directors today announced the departure Cheryl Robillard, PT, WCC, CLT. Robillard has reached the five-term limit of service.

December 13, 2018
·
1 min read
Business

When Your Holiday Guest Is An Addict

It’s every holiday host’s worse nightmare: a guest who is an alcoholic or a drug addict. When not inviting the guest — a loved one, a professional partner or associate — is not an option, how do you prepare for the worst-case scenario?

December 13, 2018
·
2 min read